C57B1/6 male mice with chronic trichinellosis, and age-matched uninfected control mice, were inoculated with B16 melanoma cells. Tumour development was inhibited in the infected animals. In the infected tumour-bearing mice, the tumour induction intervals were longer and the tumour size was subsequently smaller than in the control mice. Moreover, when the number of tumour cells in the inoculum was less than that required to produce 100% tumour incidence in the uninfected mice (<1 x 10 4 cells), significantly more of the mice with an infection of 2 months duration remained tumour-free. These results were significant at the P<005 level.
INTRODUCTION
During the past eleven years scattered reports have indicated that the nematode parasite Trichinella spiralis may enhance the host's defence mechanism^) against spontaneously arising neoplasia. Weatherly (1970) observed that female Swiss mice bearing a chronic sub-lethal infection with T. spiralis had a significantly lower incidence of spontaneous mammary tumours. Keller, Ogilvie & Simpson (1971) reported that a mammary adenocarcinoma (spontaneous origin in A-strain mice) did not grow at all within a 30-day period after subcutaneous (s.c.) transplantation into syngeneic mice, or grew more slowly, if the recipient mice were infected with another nematode, Nippostrongylus brasiliensis, 7 days before, on the same day as, or 7 days after tumour transplantation. Meerovitch & Bomford (1977) demonstrated that peritoneal macrophages harvested from outbred male albino mice (CD-I strain), 1-5 weeks after the mice were infected with T. spiralis, were cytostatic to Rl leukaemia cells (origin, CBA mice) in vitro. Wing, Krahenbuhl & Remington (1979) found that peritoneal macrophages harvested from female C57B1/6J mice from day 11 until day 40 post-7 7 , spiralis infection were cytostatic for syngeneic El-4 and allogeneic P815 tumour cells in vitro, and they were also cytotoxic in vitro when harvested and tested with El-4 tumour cells on day 14 post-infection.
The most spectacular results were obtained by Molinari & Ebersole (1977) . They reported that hybrid B6D2F1 female mice (H -2 d / b histocompatibility alleles) (C57B1/6 mothers ( H -2 b / b ) and DBA/2 fathers (H-2 d / d )) bearing a chronic T. spiralis infection (duration 6 months, infective dose 200 larvae) were completely resistant to 5 x 10 5 B16 melanoma tumour cells (s.c.) harvested from C57B1/6 mice: the uninfected control mice all developed tumours and died. The relevance of these results to the question 'does the presence of viable T. spiralis larvae in mice confer enhanced resistance against neoplastic cells of spontaneous origin' is not clear since the choice of tumour model in the study did not take into consideration two concepts of current importance in cancer research: the use of syngeneic experimental systems as models of naturally occurring cancer (Hewitt, 1978) , and the role of natural killer cells as a first level of defence against spontaneously arising neoplasia (Kiessling & Wigzell, 1979) and their genetic control (Herberman & Holden, 1978) . The results presented below show that the development of B16 melanoma in male C57B1/6 mice did not occur, or occurred significantly more slowly, if the mice bore a chronic T. spiralis infection. This is the first time to our knowledge that anti-neoplastic effects of T. spiralis infections have been shown in an experimental syngeneic model that closely resembles naturally arising neoplasia: B16 melanoma is a weakly immunogenic, spontaneously metastasizing, transplantable tumour that arose spontaneously in low incidence (n = 3) in male C57B1/6J mice in 1957 and has been subsequently maintained in these mice (Fidler, Gersten & Hart, 1978; Hewitt, 1978) . T. spiralis is intracellular during both the intestinal phase (Despommier, Sukhdeo & Meerovitch, 1978; Wright, 1979) and the muscle (chronic) phase of trichinellosis, and in this respect the parasite resembles the known non-specific immunomodulators such as BCG, Toxoplasma gondii and Corynebacterium parvum (Allison, 1978) .
MATERIALS AND METHODS

Animals
Syngeneic male C57Bl/6NCrlBR mice, routinely delivered by Canadian Breeding Farm and Laboratories (St Constant, Quebec) when they were 43 days old, were used throughout. After random distribution, 6/shoebox cage, individual mice in each cage were coded by cutting off forelimb toes. In each experiment, control and experimental mice were age-matched and delivered on the same day. Food (Purina mouse chow) and water were given ad libitum. Tumour B16 melanoma (s.c. tumour system B158R, transplant generation 03) was obtained in vivo in male C57B1/6 mice from Mason Research Institute, Mass., USA. The tumour was maintained subcutaneously for 3 generations; subsequent generations were maintained intramuscularly (i.m.) in the right thigh and the results reported below were obtained with i.m. tumours, generations 9-13. The i.m. model proved superior to the s.c. one: tumours did not ulcerate and tumour growth could be measured by monitoring the diameter of the inoculated thigh relative to the contralateral thigh. Moreover, since cells injected into the thigh muscle do not pass the inguinal barrier, secondary foci of tumour growth could be regarded as true metastases.
Single-cell suspensions of viable tumour cells were obtained as follows: non- (Schrek, 1979) . Mice were inoculated in the right thigh with 0 -l ml of Medium 199 containing the appropriate number of viable cells, using a 1-0 ml tuberculin syringe fitted with a 26-gauge needle; animals that bled were discarded.
Subsequent to inoculation, the widest lateral and anterio-posterior diameters of both thighs were measured with fine calipers (0-05 mm divisions) 2 or 3 times /week until the experiment was terminated. For each mouse the average radius of the normal thigh was subtracted from that of the inoculated thigh to give the tumour radius. A tumour was considered present when this difference was 0*2 mm or more, because a difference of this magnitude invariably increased with time. Experiments were terminated when the average control tumour radius exceeded 6 mm in order to spare the animals unnecessary distress; mice were killed with carbon dioxide. Carcasses were dissected and lymph nodes, liver, spleen, kidneys, lungs and brain were examined for metastases.
Parasite
The strain of T. spiralis used in this study was isolated from a domestic pig in 1959 and has been serially passaged since then in rats and mice at the Institute of Parasitology.
Experimental mice were administered the appropriate number of live infective larvae by intragastric intubation in 0-5 ml of saline; larvae were counted in a McMaster nematode egg-counting chamber. Infective larvae were obtained following the digestion of infected mouse musculature at 37 °C in artificial gastric juice (0-5 % concentrated HC1 and 0-3 % pepsin in water) for 2-3 h on a magnetic stirrer.
Statistical analyses
Average T.I.I.s and average tumour radii, in the different groups of tumourbearing mice in any given experiment, were compared by Duncan's New Multiple Range test (comparison of 3 or more groups) or by Student's £-test (comparison of 2 groups only) (Sokal & Rohlf, 1969) . When data from 3 or more groups with use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182000052768 unequal replication were compared, significant studentized ranges were multiplied by S rather than by 8%-, and these intermediate ranges were then multiplied by the appropriate value of V[l(^/ r i) + (^/ r J)] f°r a n y desired comparison*. The significance of tumour-free infected mice (compared to tumour-free control mice) was determined by the Fisher Exact Probability Test (Siegel, 1956) .
In some long-term experiments the value of n, or of r, is an odd number (e.g. n = 57 or 58, not 60, or r = 18 or 19, not 20): C57B1/6 mice have about 3 % malocclusion of the jaw (Staats, 1976) and mice that developed this syndrome became emaciated and were discarded. naturally resistant and the tumour did not take: tumour-free mice in these experiments were observed for 6-12 months.
The data in Table 1 show that decreasing the number of tumour cells inoculated increased the average T.I.I. The value of S 2 /X was also higher when the number of inoculated cells was low-a result of the greater spread of the T.I.I.-and indicated that in experiments with low inocula, larger numbers of mice should be used. In all of the experiments reported below, in which the differences in size between tumours in infected mice and tumours in uninfected mice were compared using parametric statistics, the value of S 2 /X was 1 or < 1. The results listed in Table 1 also show that mice of 16-30 weeks of age were generally more susceptible to the tumour than were the younger 8 to 11 -week-old mice. The average T.I.I, after inoculation with similar numbers of tumour cells tended to be shorter in the older mice. Moreover, final tumour incidence in the older mice given inocula of less than 10 4 cells was higher.
Summary of preliminary experiments
In each of 3 early experiments infective doses of 5, 10 or 20 T. spiralis larvae/g body weight (100, 200 and 400 larvae/20 g mouse, respectively) were administered I month (Exp. 1, n = 24, r = 6*), 2 months (Exp. 2, n = 20, r = 5) and 3 months (Exp. 3, n = 24, r = 6) prior to an inoculum of 06 x 10 5 , 10 x 10 4 and 11 x 10 4 B16 tumour cells, respectively; age-matched control mice were uninfected. The results (compiled and analysed as those shown in Tables 2, 3 and 4) from these preliminary experiments may be summarized as follows. (1) Infected mice and control mice all developed tumours within 28 days, except in Exp. 3, when the 6 mice administered 5 larvae/g were mistakenly inoculated with 11 x 10 3 tumour cells, not with II x 10 4 cells as intended, and in 3 of these mice tumours did not develop. (2) Tumour development in all groups of infected mice was invariably slower than in * n = no. of mice in the experiment, r = no. of mice/experimental group. uninfected mice, whether the parameter of development was taken to be the average T.I.I, or comparable tumour size on any given day. (3) Once tumours were detectable, there was no difference in their growth rates, so that the growth curves of tumours in infected and control mice were superimposable. However, since the average T.I.I, was longer for any given inoculum in the infected mice, the growth curves of their tumours were shifted further along the time axis, as if fewer tumour cells had been injected. (4) Tumour development in mice administered 20 larvae/g (but not in those administered 5 or 10 larvae/g) was significantly slower than in control mice in Exps 1 and 2 (P <005). These preliminary results led to the following two experiments, which are described in detail.
Inhibition of, and protection against, -SI6 melanoma in infected male mice
In Exp. 4 (n = 77), 68-day-old mice were administered 0 (controls, r = 29), 5 (r = 36) and 20 (r = 12) T. spiralis larvae/g body weight, 78 days prior to receiving an inoculum of 0*8 x 10 3 tumour cells. (The mice were therefore approximately 5 months old on the day of inoculation (day 0).) In the infected mice, the average T.I.I.s were longer (Table 2 ) and tumour size was smaller on any given day (Table 3) than in the uninfected controls. In this experiment an infective dose of 5 larvae/g appeared to be more effective than 20 larvae/g. With a dose of 5 larvae/g the average T.I.I, was significantly longer and subsequent tumours were significantly smaller throughout than in the uninfected controls, whereas the induction interval was not lengthened significantly in mice given 20 larvae/g and their tumours were significantly smaller than control tumours only on days 31 and 35 (when tumour-bearing mice were killed). However, the statistical analysis is prejudiced unfavourably towards the 20 larvae/g group since it contained less than half the number of mice in each of the other two groups. The fact that 7/36 (19-5%) mice infected with 5 larvae/g, 2/12 (16-9%) mice infected with 20 larvae/g, but only 2/29 (6 -9%) of the control mice have not developed tumours to date (10 months later) is of considerable interest, even though the protection conferred by the 2 -5 month T. spiralis infections was not statistically significant at the P<0 -05 level (Table 2 ).
In Exp. 5 (n = 57), 52-day-old mice were administered 0 (controls, r = 19), 5 (r = 20) and 20 (r = 18) T. spiralis larvae/g 60 days before they were inoculated with 20 x 10 2 tumour cells. (The mice were therefore approximately 35 months old on the day of inoculation.) However, 7/18 (38 -8%) mice infected with 20 larvae/g, 4/20 (20%) mice infected with 5 larvae/g and only 1/19 (5-3%) of the uninfected mice have not developed tumours to date (6 months post-inoculation): protection against the tumour was significant (P<0-02) in the group of mice administered 20 larvae/g (Table 2 ). In both groups of infected tumour-bearing mice, average T.I.I.s were significantly longer (Table 2 ) and tumours were significantly smaller (with 20 larvae/g from day 21 to day 30, with 5 larvae/g from day 28 to day 30; Table 4) than in the uninfected control mice. In this experiment, a dose of 20 larvae/g was more effective than that of 5 larvae/g in retarding tumour development, as well as in protecting the mice against tumour take. In mice with the heavier infection the average T.I.I, was significantly longer and tumours were significantly smaller on day 30 (when tumour-bearing mice were killed) than in mice with the lighter infection.
Reduced anti-BlQ effect of long-term T. spiralis infection in older mice
In a long-term experiment, the response of infected male and female mice to an inoculum of 1 x 10 5 B16 tumour cells was monitored in order to investigate whether the results of Molinari & Ebersole (1977) with female hybrid mice could be approximated in a syngeneic model. The age of the mice and the duration of the infection were the same as those in the experiment by Molinari & Ebersole (1977) .
Two-month-old female (r = 21) and male (r = 21) C57B1/6 mice were administered T. spiralis in a dose of 20 larvae/g; 2-month-old uninfected females (r = 27) and males (r = 22) were set aside as controls. After 5*5 months, when the mice were 7 -5 months old (day 0), they were inoculated each with 1-1 x 10 5 tumour cells (harvested from tumours in female mice). Legs were subsequently measured for 3 weeks (when the experiment was terminated) and average T.I.I.s and tumour radii are listed in Table 5 (a) and (b), respectively.
All 91 mice developed tumours. The average T.I.I, was the same in both female use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182000052768 groups (9-3 days) and, although it was somewhat lengthened in infected males (9-1 days) compared to control males (8 -5 days), the difference was not significant. Tumours in male controls and in female controls were similar in size throughout; tumours in infected females were not significantly different in size from tumours in either control group; however, tumours in infected males were significantly smaller than those in both control groups from day 14 to day 21. Although the mean radius of developing tumours was largest in control males and smallest in infected females on day 10, tumours in both female groups grew more rapidly within the next 4 days than did tumours in either of the male groups (see Table 5 (c)), increasing roughly 4-fold in the females and 3-fold in the males. After day 14, growth increments were similar in all 4 groups. In all other experiments the growth rates of established tumours in the different groups within an experiment were remarkably similar.
Metastases
Examination of mice when the experiments were terminated showed that T. spiralis infections neither inhibited nor enhanced the metastic potential of the primary tumour.
Metastases were found in the lungs of approximately 30 % of the mice in all groups, and the average number of discrete foci in the lungs of infected groups did not differ from the number in the control groups. There was no apparent use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182000052768 relationship between the size of the primary tumour and the incidence of secondary foci in the lungs. Metastases were usually found in the right lumbar lymph node of all mice bearing primary tumours.
DISCUSSION
The results to date clearly show that the i.m. development of B16 melanoma was significantly inhibited in male C57B1/6 mice infected with T. spiralis 1-3 months prior to tumour cell challenge. Tumours appeared later in infected tumour-bearing mice and were subsequently smaller than in the uninfected control mice on any given day (Exps 4 and 5). Moreover, when the inoculum of tumour cells was low, significantly more infected mice than uninfected mice were resistant to the tumour (Exp. 5). The infections therefore produced the same effect as would have a smaller tumour cell inoculum, suggesting that some of the injected tumour cells were killed or prevented from multiplying.
It would appear from the results of Exp. 5 that an infection resulting from a relatively high infective dose has a greater anti-cancer effect than one resulting from a low infective dose (5 larvae/g), at least when the comparative infections are of 2 months duration at the time the mice are challenged with tumour cells. Since the age of the mice affects their response to injected tumour cells, and generally older mice are more susceptible (Table 1) , further experiments are needed before it can be determined whether or not a high infective dose is always more effective than a low dose.
When tumour cells were harvested from female C57B1/6 mice and 11 x 10 5 cells were injected into age-matched males and females 5-5 months after thay had been infected with 20 T. spiralis larvae/g, tumour development was completely unaffected in the infected females. Although tumours in the infected males were significantly smaller than in the uninfected males, the average T.I.I, was not significantly longer in the infected group. Whether this reduced anti-cancer effect (compared to the results in earlier experiments) was due to the greater age of the mice or to the older infection or to the fact that the tumour cells came from female mice rather than male mice (unlike the other experiments) is not clear. What is clear is that the results of Molinari & Ebersole (1977) with the B6D2F1 hybrid female mice, in which a T. spiralis infection of 6 months duration (infective dose 10 larvae/g) conferred complete protection against 5x 10 s B16 melanoma cells (harvested from C57B1/6 mice) administered s.c, could not be repeated in the C57B1/6 i.m. syngeneic tumour system. The hybrid mice had a much greater innate resistance to B16 melanoma: the authors report tumour induction intervals of 17 tumour cells in their dose-response study; in the old mice used in the experiment they state that 'appearance of neoplastic lesions in some of the control mice was evident by 20 days after challenge and the frequency of tumours increased until, by day 28, 23/24 mice in this group exhibited demonstrable neoplasia'. In the syngeneic model, the average tumour induction intervals after similar inocula were much shorter (Table 1) , and in the experiment with the old female mice the induction interval was 9-3 days and all mice had tumours by day 14. In early experiments (not reported here) s.c. tumours were palpable in young mice 7-9 days use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182000052768
after inoculation with 3 x 10 5 viable tumour cells; thus, the i.m. route of inoculation did not shorten the T.I.I, in the syngeneic system. The elevated innate resistance of the hybrids may have been due to the increased NK cell activity known to occur in B6D2F1 mice (Clark & Harmon, 1980) , or to cytotoxic T lymphocytes. Molinari & Ebersole (1977) harvested the tumour cells from syngeneic C57B1/6 mice (sex unstated) and these cells may have elicited a cytotoxic T cell response in the Fl hybrids (Nakano, Nakamura & Cudkowicz, 1981) . Whether the T. spiralis infection raised the level of activity of either one of these cell populations directly or indirectly, or whether it activated macrophages (as the authors suggest), which then may have acted directly on the proportion of inoculated tumour cells that survived the host's natural defence mechanisms, is not known.
The results of the work reported here show that the presence of viable T. spiralis larvae in mice confers enhanced resistance against neoplastic cells of syngeneic origin. The mechanism(s) that inhibit(s) syngeneic tumour development in mice with trichinellosis is (are) not known. In vitro work has shown that peritoneal macrophages from T. spiralis-infected mice are tumoristatic or tumoricidal (Meerovitch & Bomford, 1977; Wing et al. 1979) . Eugui & Allison (1980) have demonstrated that strains of mice (including C57B1/10) that can survive infections with Plasmodium chabaudi and Babesia microti have increased NK cell activity after infection with these protozoan parasites, whereas the strains that succumb to the infections do not. Activated macrophages secrete interferon (Allison, 1978) and NK cell activity is increased by interferon (Kiessling & Wigzell, 1979) . It is highly probable that the anti-neoplastic effect of trichinellosis is due to an elevation or potentiation of non-specific cell-mediated immunity, in which macrophages or natural killer cells, or both, are the effector cells.
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